Inhibition of EIF2α Dephosphorylation Decreases Cell Viability and Synergizes with Standard-of-Care Chemotherapeutics in Head and Neck Squamous Cell Carcinoma.

Cancers (Basel) · 2023 · PMC10670742 · PMID 38001610

Europe PMC DOI

hedged sentence

0.0583

closest p · 1.2× alpha

0.0583

boldest claim

The sentences

did not reach statistical significancep = 0.0583so close (0.05 < p ≤ 0.1)

The phosphorylated and unphosphorylated EIF2α ratio was higher in HNSCC, but the trend did not reach statistical significance ( p = 0.0583). 3.3.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.